0001181431-13-064117.txt : 20131220 0001181431-13-064117.hdr.sgml : 20131220 20131220165603 ACCESSION NUMBER: 0001181431-13-064117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131218 FILED AS OF DATE: 20131220 DATE AS OF CHANGE: 20131220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QVT Associates GP LLC CENTRAL INDEX KEY: 0001290166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 131292151 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-705-8800 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 rrd398189.xml FORM 4 X0306 4 2013-12-18 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001290166 QVT Associates GP LLC 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 0 0 1 0 Common Stock, $0.001 par value 2013-12-18 4 S 0 89812 3.06 D 11530338 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2013-12-19 4 S 0 100000 3.09 D 11430338 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. Common Stock, $0.001 par value 2013-12-19 4 S 0 32800 3.15 D 11397538 I Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. On December 18, 2013, QVT Fund IV LP sold 11,535 shares of Common Stock, Quintessence Fund L.P. sold 9,950 shares of Common Stock and QVT Fund V LP sold 68,327 shares of Common Stock. On December 19, 2013, QVT Fund IV LP sold 17,055 shares of Common Stock, Quintessence Fund L.P. sold 14,713 shares of Common Stock and QVT Fund V LP sold 101,032 shares of Common Stock. As a result, QVT Fund IV LP directly beneficially owns 1,463,894 shares of Common Stock, Quintessence Fund L.P. directly beneficially owns 1,262,772 shares of Common Stock and QVT Fund V LP directly beneficially owns 8,670,872 shares of Common Stock. QVT Associates GP LLC is the general partner of QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. (together with QVT Fund IV LP, and QVT Fund V LP, the "Funds"). QVT Financial LP is the investment manager for the Funds and therefore may be deemed the beneficial owner of the Common Stock held by the Funds. QVT Financial GP LLC is the general partner of QVT Financial LP and therefore may be deemed the beneficial owner of Common Stock beneficially owned by QVT Financial LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. /s/ Tracy Fu, Managing Member 2013-12-20